Namita Thapar

Executive Director, Emcure Pharmaceuticals / Founder, Arth by Emcure / Angel Investor

Reviewed Updated May 1, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Pune, India
Check Size ₹10L-₹1Cr (Shark Tank deals); larger checks for select angel rounds
Last Verified Investment Palmonas (Shark Tank India Season 4 (partial exit reported May 2026)) — Mar 2025
Social LinkedIn
Stage Focus
pre-seed seed early-stage
Sector Focus
healthtech healthcare wellness consumer d2c womens-health medtech pharma food-and-beverage apparel edtech

Background

Namita Thapar (born 21 March 1977, Pune, Maharashtra) is Executive Director of Emcure Pharmaceuticals Ltd. and one of the most visible angel investors in India through her role as a “Shark” on Shark Tank India 1 2. She is a Chartered Accountant credentialed by the Institute of Chartered Accountants of India (ICAI) and holds an MBA from Duke University’s Fuqua School of Business (Class of 2001) 1 3. Her father, Satish Mehta, founded Emcure in 1981 1 4.

After her MBA, Thapar spent six years at Guidant Corporation in the United States (since acquired by Abbott) in business-finance roles 3 5. She returned to India in 2007 and joined Emcure as Chief Financial Officer; her responsibilities subsequently expanded to include India business operations, mergers and acquisitions, IT, global compliance, HR, and domestic marketing 3 5. As Executive Director she now oversees Emcure’s India business, which markets approximately 150 brands across 17 therapeutic areas to more than 200,000 physicians 3.

Emcure Pharmaceuticals listed on the NSE and BSE on 10 July 2024 at ₹1,325 per share — a 31.4% premium to the IPO issue price of ₹1,008 — after a ₹1,952 crore book-built offering 4 6. The IPO comprised a ₹800 crore fresh issue and a ₹1,152.03 crore offer for sale 4 6. The QIB portion was subscribed 195.83 times, non-institutional 48.32 times, and retail 7.21 times 4. Thapar, listed as a promoter, held approximately 63 lakh shares (a ~3.5% stake) pre-issue and sold over 12.68 lakh shares through the OFS, with her weighted-average cost of acquisition reported at ₹3.44 per share 4 6. Emcure reported revenue of ₹6,658 crore for FY2024 4.

Thapar has appeared as a Shark on Sony Entertainment Television’s Shark Tank India across Seasons 1 through 5 1 7. Across Seasons 1-3 she invested ~₹30.2 crore across 85 on-air deals — 22 deals worth ₹6.383 Cr in S1, 41 deals worth ₹13.889 Cr in S2 (the season’s top investor), and 22 deals worth ₹9.95 Cr in S3 (her largest S3 cheque was ₹1 Cr for 1% equity plus a 1% royalty until recouped, in Cosmix) 7 8 9. Thapar launched a women’s-health YouTube talk show, “Uncondition Yourself with Namita Thapar,” during the COVID-19 pandemic 10 11. She founded Incredible Ventures Ltd., an entrepreneurship-education company for ages 11-18, and Arth by Emcure, a women’s-health platform 3 11 12. Board affiliations include the India Regional Advisory Board of Duke Fuqua School of Business, the TiE Mumbai Board of Trustees, and active membership in Young Presidents Organization 3. Awards include The Economic Times ‘40 under Forty’ Award (2018) 1 3.

Stated Thesis

Thapar publicly frames her angel investing as expertise-led: she screens for sectors she understands and is open about declining outside her circle of competence. Her on-air catchphrase, widely reported in coverage of Shark Tank India, is some variant of: “Yeh meri expertise nahi hai, toh I am out” 13. Press and her own social posts describe her bias toward founders building in women’s health, healthcare, wellness, and youth-oriented consumer brands 12 14.

On women entrepreneurs, in a 2021 interview with Entrepreneur India, Thapar said: “Women entrepreneurs should remember that rather than having discussions around gender, the discussions should be around numbers, results, profitability and outcomes, which helps keep the conversations objective” 14.

On the rationale for backing women’s-health ventures, in the same interview she said: “I had come across a World Economic Forum Report which said that out of 156 countries surveyed on women’s health, India was ranked 155th. I felt it was our responsibility to spread awareness about women’s health, as most people don’t know about illnesses, the symptoms, and diagnosis and then there are also taboos around it” 14.

On Shark Tank India and Indian founders, in a December 2021 Poets&Quants interview she said: “India is the third-largest startup ecosystem globally. The sheer uniqueness and diversity of founders and ventures on this show was inspiring” and “In this show, not only were three of the seven sharks women (highest globally), but 15% of the ventures that got funded had solo female founders” 15.

Inferred Thesis

Thapar’s investment activity has two distinct streams that should not be conflated: (a) on-air Shark Tank India commitments, which are heavily televised but where a meaningful share never close after due diligence, and (b) private angel cheques. The analysis below is based on ~30 deals with verifiable terms drawn from Seasons 1-4 on-air listings 7 8 16.

Shark Tank India deal volume (on-air commitments): - Season 1: 22 deals, ₹6.383 Cr 9 - Season 2: 41 deals, ₹13.889 Cr — top investor of the season 7 7 - Season 3: 22 deals (21 by one tally with 5 solo deals), ₹9.95 Cr 9 - Season 4: confirmed cheques include Better Nutrition, Tikitoro, Confect, Palmonas; season totals not separately reported per Shark 16 17

Across S1-S3 alone, ~85 on-air commitments totalling ~₹30.2 Cr 7 9. Note: on-air commitments are not the same as closed deals — coverage of S1-S3 has repeatedly highlighted that 30-50%+ of pitched deals across all Sharks do not close post-DD; specific failure rates for Thapar’s deals are not separately reported.

Sector distribution of 30 sector-tagged on-air deals from public listings 16: - HealthTech / MedTech / Wellness: 7 of 30 (23%) — Menstrupedia, Thinkerbell Labs (assistive), The Renal Project, Sunfox Technologies (Spandan ECG), Watt Technovations, Janitri (S2), Cosmix (S3) - Food & Beverage / FoodTech: 9 of 30 (30%) — Skippi Ice Pops, COCOFIT, Beyond Water, InACan, Wakao Foods, Nomad Food Project, TagZ Foods, JhaJi Store, Better Nutrition (S4) - Apparel / Fashion / D2C consumer: 5 of 30 (17%) — Bummer, Girgit, Very Much Indian, Farda, Auli Lifestyle - EdTech / Education: 2 of 30 (7%) — Thinkerbell Labs, AAS Vidyalaya - Media / OTT / Sports: 2 of 30 (7%) — STAGE, Kabaddi Adda - Personal care / Beauty / Wellness consumer: 3 of 30 (10%) — Nuutjob, Auli Lifestyle, Tikitoro (S4) - Other (AgriTech, retail/handicrafts, jewellery, storage, automotive): 4 of 30 (13%) — Brainwired, Rare Planet, Palmonas (S4), Altor, Store My Goods

The HealthTech and women’s/maternal health concentration is the clearest distinctive signal in Thapar’s portfolio — consistent with both her Emcure operating background and her public advocacy via “Uncondition Yourself” and Arth by Emcure 10 12.

Stage distribution: Predominantly pre-seed and seed. Shark Tank cheque sizes typically range ₹8L-₹1.67Cr per deal, with equity asks generally 1-25% (occasionally higher when paired with debt or royalty structures) 16. Larger deals are sometimes shared across multiple Sharks.

Founder profile patterns: Thapar has shown a clear preference for mission-driven founders in healthcare and women-focused consumer categories, often with strong personal stories. Her “Uncondition Yourself” platform and her LinkedIn commentary on portfolio companies emphasise her own active role in connecting founders to the Emcure network (hospitals, doctors, distribution) — particularly for medtech ventures such as Janitri and Spandan 12 18.

Co-investor patterns: On Shark Tank India, Thapar most frequently shares deals with Aman Gupta (boAt), Vineeta Singh (SUGAR Cosmetics), Peyush Bansal (Lenskart), Anupam Mittal (Shaadi.com), Ashneer Grover (then BharatPe), and Ghazal Alagh (Mamaearth) 7 16 19.

Reported returns / partial exits: Per Storyboard18 and Business Today coverage, several of Thapar’s Shark Tank investments have generated reported paper or partial-exit returns: Skippi Ice Pops (₹20L cheque tracked to ~₹6 Cr value by 2024), Rare Planet (partial exit January 2024), and Palmonas (reported “9X in 14 months” partial exit, with the company subsequently raising ₹350 Cr for expansion) 17 19. These are returns reported by the press and the investor; this profile does not independently verify exit waterfalls.

Notable gap between stated and actual thesis: Thapar’s stated focus is healthcare and women’s wellness, but the largest single sector in her on-air portfolio by count is food & beverage. Healthtech is highly concentrated but not the modal sector — a function of Shark Tank deal flow rather than disinterest.

Portfolio

This table covers approximately 30 Shark Tank India deals with verifiable terms; press reports cite “over 100” total investments across her on-air and private activity, so this represents a meaningful subset of named deals 1 16. “STI Sx” denotes Shark Tank India deals from the named season; on-air commitments are not always the same as closed deals.

Company Year Stage Sector Source
Bummer 2022 STI S1 Apparel/D2C 16 19
Skippi Ice Pops 2022 STI S1 Food & Beverage 16 19
Menstrupedia 2022 STI S1 HealthTech/Women’s Health 16
Girgit 2022 STI S1 Fashion 16
Brandsdaddy 2022 STI S1 Consumer Services 16
Very Much Indian 2022 STI S1 E-commerce/Apparel 16
STAGE 2023 STI S2 Media/OTT 16
Altor 2022 STI S1 Automotive Safety 16
Nuutjob 2023 STI S2 Personal Care 16 19
Farda 2023 STI S2 Apparel 16
Auli Lifestyle 2022 STI S1 Beauty/Wellness 16
Thinkerbell Labs 2022 STI S1 EdTech/Assistive 16
The Renal Project 2022 STI S1 HealthTech 16
COCOFIT 2022 STI S1 Food & Beverage 16
Beyond Water 2022 STI S1 Beverages 16 19
AAS Vidyalaya 2022 STI S1 EdTech 16
Brainwired 2022 STI S1 AgriTech 16
InACan 2022 STI S1 Beverages 16
Sunfox Technologies (Spandan) 2022 STI S1 HealthTech/MedTech 16 18
Rare Planet 2022 STI S1 Retail/Handicrafts 16 19
Watt Technovations 2022 STI S1 MedTech 16
Wakao Foods 2022 STI S1 Plant-based F&B 16 20
Kabaddi Adda 2022 STI S1 Sports/Media 16
Nomad Food Project 2022 STI S1 Food & Beverage 16
TagZ Foods 2022 STI S1 Snacks 16
Janitri 2023 STI S2 HealthTech/Maternal 18 19
The Bear House 2023 STI S2 Apparel 19
Cosmix 2024 STI S3 Wellness/Supplements 9
Arata 2024 STI S3 Haircare/Personal Care 19
Better Nutrition 2025 STI S4 Food & Beverage/Nutrition 16 17
Tikitoro 2025 STI S4 Kids’ Personal Care 16 17
Confect 2025 STI S4 FoodTech 16 17
Palmonas 2025 STI S4 Jewellery/D2C 17

Note: dates labelled by season-aired year reflect on-air date of commitment, not necessarily date of legal close; press has documented multiple Shark Tank India cases industry-wide where on-air deals do not close post due diligence.

In Their Own Words

“India is the third-largest startup ecosystem globally. The sheer uniqueness and diversity of founders and ventures on this show was inspiring.” — Namita Thapar, interview with Poets&Quants, December 20, 2021 15

“In this show, not only were three of the seven sharks women (highest globally), but 15% of the ventures that got funded had solo female founders.” — Namita Thapar, Poets&Quants, December 20, 2021 15

“I am very passionate about moving the needle on women’s health. Awareness and diagnosis remain major concerns and a lot needs to be done here.” — Namita Thapar, Poets&Quants, December 20, 2021 15

“The MBA definitely stays relevant. It gives you a structured way of thinking through problems, gives you a good understanding of various functions in a corporate.” — Namita Thapar, Poets&Quants, December 20, 2021 15

“Women entrepreneurs should remember that rather than having discussions around gender, the discussions should be around numbers, results, profitability and outcomes, which helps keep the conversations objective.” — Namita Thapar, Entrepreneur India interview 14

“I had come across a World Economic Forum Report which said that out of 156 countries surveyed on women’s health, India was ranked 155th. I felt it was our responsibility to spread awareness about women’s health, as most people don’t know about illnesses, the symptoms, and diagnosis and then there are also taboos around it.” — Namita Thapar, Entrepreneur India interview 14

“The good thing about social media has been that now I can use the power of my voice to talk on important topics, since people will listen. It’s a big responsibility, and should be used well.” — Namita Thapar, Entrepreneur India interview 14

“Today I met with 2 incredible Shark Tank founders at our Emcure office in Mumbai. Both have gone from sales of 10 lakhs a month to currently 50 lakhs a month. I promised them Emcure networks & today they met with our Emcure senior leaders.” — Namita Thapar, LinkedIn / Business Today, April 26, 2023 18

What Founders Say

No independently sourced founder testimonials with verbatim, in-quotation-marks quotes about working with Namita Thapar as an investor were located in publicly available reporting during this research pass. Business Today’s April 2023 feature on Spandan and Janitri describes both founders’ work and growth metrics, but the published founder statements are paraphrased rather than presented as direct quotes 18. Until verbatim founder statements can be sourced (e.g., from a podcast transcript, interview, or social-media post by a portfolio founder), this section will remain conservative rather than padded.

Connections

  • Executive Director, Emcure Pharmaceuticals Ltd. — listed promoter alongside Satish Mehta (founder, father) and other family promoters at IPO (July 2024) 4 5 6
  • Founder, Incredible Ventures Ltd. — entrepreneurship education for ages 11-18, operating across Mumbai, Delhi, Bangalore, Pune, Chennai, and Ahmedabad 3
  • Founder, Arth by Emcure — women’s health platform (current Instagram bio identifies her as Founder, @arthbyemcure) 11 12
  • Host, “Uncondition Yourself with Namita Thapar” — YouTube talk show on women’s health, launched during COVID-19 pandemic 10 11
  • Frequent Shark Tank India co-investor with Aman Gupta (boAt), Vineeta Singh (SUGAR Cosmetics), Peyush Bansal (Lenskart), Anupam Mittal (Shaadi.com), Ashneer Grover (then BharatPe), Ghazal Alagh (Mamaearth), Ritesh Agarwal (OYO, S4), and others across Seasons 1-5 7 16 17 19 20
  • Prior employer: Guidant Corporation (now Abbott), six years in business-finance roles in the United States 3 5
  • Board member, India Regional Advisory Board, Duke Fuqua School of Business 3
  • Trustee, TiE Mumbai Board of Trustees 3
  • Member, Young Presidents Organization (YPO) 3
  • NITI Aayog initiatives: Participant in “Women Entrepreneurship Platform,” “Digital Health Task Force,” and “Champions of Change” programmes 3

Sources

  1. Wikipedia, “Namita Thapar,” accessed May 2026. https://en.wikipedia.org/wiki/Namita_Thapar↩↩↩↩↩↩

  2. Sharktank-india.com, “Namita Thapar - Emcure Pharma Executive & Shark Tank India Judge,” accessed May 2026. https://sharktank-india.com/namita-thapar/↩

  3. Duke Fuqua School of Business, “Namita Thapar - Alumni Ambassadors,” accessed May 2026. https://www.fuqua.duke.edu/student-network/alumni-ambassadors/namita-thapar↩↩↩↩↩↩↩↩↩↩↩↩↩

  4. Business Standard, “Namita Thapar-backed Emcure Pharma IPO opens: GMP, price, apply or not?,” July 3, 2024. https://www.business-standard.com/markets/news/emcure-pharma-ipo-opens-today-here-s-what-gmp-indicates-apply-or-not-124070300077_1.html↩↩↩↩↩↩↩

  5. Emcure Pharmaceuticals, “Namita Vikas Thapar - Leadership,” accessed May 2026. https://www.emcure.com/leadership/namita-vikas-thapar/↩↩↩↩

  6. Upstox, “Namita Thapar’s Emcure Pharma IPO listing: Shares debut at 31.4% premium on NSE and BSE,” July 10, 2024. https://upstox.com/news/market-news/ipo/namita-thapar-emcure-pharma-ipo-listing-shares-list-on-nse-and-bse-premium-gmp-online-stock-share-price/article-100793/↩↩↩↩

  7. Free Press Journal, “Shark Tank India Season 2: Sharks invest Rs 34.63 crores invested in so far, Namita Thapar continues to be highest investor,” accessed May 2026. https://www.freepressjournal.in/business/shark-tank-india-season-2-sharks-invest-rs-3463-crores-invested-in-so-far-namita-thapar-continues-to-be-highest-investor↩↩↩↩↩↩↩↩

  8. Jumpstart Magazine, “Shark Tank India Season 1-3: How Much Money Have These Top Sharks Invested?,” accessed May 2026. https://www.jumpstartmag.com/shark-tank-india-season-1-3-how-much-money-have-these-top-sharks-invested/↩↩

  9. Koimoi via IMDb, “Shark Tank India Season 3: Aman Gupta Beats S2 Winner Namita Thapar By 53.83% Higher Investments, Total 89 Deals Worth 78.26 Crore,” accessed May 2026. https://www.imdb.com/news/ni64517529/↩↩↩↩↩

  10. YouTube, “Uncondition Yourself with Namita Thapar” channel, accessed May 2026. https://www.youtube.com/channel/UCDZh2x49wXQaF8KnRIsohGw↩↩↩

  11. LinkedIn post by Namita Thapar announcing health podcast ‘Uncondition Yourself,’ accessed May 2026. https://www.linkedin.com/posts/namita-thapar_i-started-my-health-podcast-uncondition-activity-7422954753418231808-EC_G↩↩↩↩

  12. Instagram, Namita Thapar (@namitathapar) profile bio, accessed May 2026. https://www.instagram.com/namitathapar/↩↩↩↩↩

  13. Finschool by 5paisa, “Namita Thapar Success Story: The Phar’Maa’ Of Shark Tank India,” accessed May 2026. https://www.5paisa.com/finschool/namita-thapar-success-story/↩

  14. Entrepreneur India, “Namita Thapar: The Power Of Good,” accessed May 2026. https://india.entrepreneur.com/women-entrepreneur/namita-thapar-the-power-of-good/44238↩↩↩↩↩↩

  15. Poets&Quants, “Meet The Duke MBA Who Became A ‘Shark’,” December 20, 2021. https://poetsandquants.com/2021/12/20/meet-the-duke-mba-who-became-a-shark/↩↩↩↩↩

  16. StartupTalky, “List of Namita Thapar Investments | Startups Funded by Namita Thapar of Emcure Pharmaceuticals,” accessed May 2026. https://startuptalky.com/namita-thapar-funded-startups/↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩

  17. Business Today, “‘9X in 14 months…’: Namita Thapar’s bet on Shraddha Kapoor backed Palmonas gives massive returns,” May 8, 2026. https://www.businesstoday.in/latest/trends/story/9x-in-14-months-namita-thapars-bet-on-shraddha-kapoor-backed-palmonas-gives-massive-returns-530430-2026-05-08↩↩↩↩↩↩↩

  18. Business Today, “From Rs 10 lakh to Rs 50 lakh sales every month; how these Namita Thapar backed start ups are acing healthtech industry,” April 26, 2023. https://www.businesstoday.in/entrepreneurship/story/from-rs-10-lakh-to-rs-50-lakh-sales-every-month-how-these-namita-thapar-backed-start-ups-are-acing-healthtech-industry-378885-2023-04-2↩↩↩↩↩

  19. Storyboard18, “From Bear House to NOOE: Namita Thapar, Peyush Bansal’s most talked-about investments,” accessed May 2026. https://www.storyboard18.com/brand-makers/from-bear-house-to-nooe-namita-thapar-peyush-bansals-most-talked-about-investments-95860.htm↩↩↩↩↩↩↩↩↩↩↩

  20. SharkTankSeason, “Wakao Foods secured investment from Namita Thapar, Vineeta Singh, Ghazal Alagh on Shark Tank India Season 1,” accessed May 2026. https://sharktankseason.com/shark-tank-india-season/season-1/wakao-foods↩↩